<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04662242</url>
  </required_header>
  <id_info>
    <org_study_id>201902287A3A0</org_study_id>
    <nct_id>NCT04662242</nct_id>
  </id_info>
  <brief_title>The Prognostic Impact of Selenium On Critical Surgical Patients</brief_title>
  <official_title>The Prognostic Impact of Selenium On Critical Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Selenium is an important trace element for human for its multiple roles such as the&#xD;
      antioxidant activity. Previous evidences showed that critically ill patients may benefit from&#xD;
      selenium supplement but the dose and results are controversial.&#xD;
&#xD;
      Patients after operations for acute abdomen usually suffer from sepsis and stress. The aim of&#xD;
      this study is to investigate the efficacy of selenium replacement in critical patients of&#xD;
      acute abdomen, to see the impact on prognosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute abdomen is a common surgical emergency and is often the result of peritonitis due to an&#xD;
      acute inflammatory process within abdominal cavity. Many of the patients with acute abdomen&#xD;
      have severe sepsis and are critically ill that require an emergency surgery.&#xD;
&#xD;
      The mortality rate of such patients are high because these patients usually have a profound&#xD;
      pathophysiological dysregulation and multiple organ dysfunction. One of the mechanism of is&#xD;
      the loss of anti-oxidative capacity of cells that fail to recover from ischemic-reperfusion&#xD;
      injury.&#xD;
&#xD;
      Selenium is an important cofactor that participate in the antioxidant activity of glutathione&#xD;
      peroxidase reaction. There are evidences that critically ill patients may benefit from&#xD;
      selenium supplement by better outcome and less mortality but the dose and results are still&#xD;
      heterogenous and inconclusive.&#xD;
&#xD;
      The aim of this study is to investigate the efficacy of selenium replacement in critical&#xD;
      patients of acute abdomen, to see if there is a significant impact on prognosis, and to&#xD;
      establish a clinical guide in the future.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">October 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mortality rate</measure>
    <time_frame>30 day</time_frame>
    <description>mortality rate in 30 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hospital length</measure>
    <time_frame>1 year</time_frame>
    <description>hospital length for current admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ventilator length</measure>
    <time_frame>1 year</time_frame>
    <description>ventilator length for current admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complication rate</measure>
    <time_frame>30 days</time_frame>
    <description>complication rate within 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>organ failure rate</measure>
    <time_frame>30 days</time_frame>
    <description>organ failure rate within 30 days</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">155</enrollment>
  <condition>Critical Illness</condition>
  <condition>Selenium Deficiency</condition>
  <condition>Trace Element Deficiency</condition>
  <condition>Acute Abdomen</condition>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>low serum selenium with selenium supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients having low serum selenium with selenium supplement given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low serum selenium with placebo supplement</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients having low serum selenium with placebo given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-low serum selenium with selenium supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients having normal serum selenium with selenium supplement given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-low serum selenium with placebo supplement</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients having normal serum selenium with placebo given</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Selenium Supplement</intervention_name>
    <description>Zelnite 400mcg/day in normal saline 100ml iv infusion for 7 days</description>
    <arm_group_label>low serum selenium with selenium supplement</arm_group_label>
    <arm_group_label>non-low serum selenium with selenium supplement</arm_group_label>
    <other_name>Zelnite</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>normal saline 100ml iv infusion for 7 days</description>
    <arm_group_label>low serum selenium with placebo supplement</arm_group_label>
    <arm_group_label>non-low serum selenium with placebo supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Intensive care unit (ICU) patients receiving abdominal surgeries for acute abdomen&#xD;
&#xD;
          -  within 48 hours post-operatively&#xD;
&#xD;
          -  stay in ICU for more than 48 hours&#xD;
&#xD;
          -  meets sepsis criteria of Sepsis-3 (2016)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  liver cirrhosis Child-Pugh score B or C&#xD;
&#xD;
          -  breastfeeding or pregnancy&#xD;
&#xD;
          -  allergy yo selenium&#xD;
&#xD;
          -  vegetative status or irreversible diseases with life-expectancy fewer than 28 days&#xD;
&#xD;
          -  End-stage renal disease under dialysis&#xD;
&#xD;
          -  Human inmunodeficiency virus infection&#xD;
&#xD;
          -  neutropenia not due to sepsis (granulocyte &lt; 1000/mm3)&#xD;
&#xD;
          -  Heart failure (New York Heart Association class III-IV) or recent myocardial&#xD;
             infarction (within 6 weeks)&#xD;
&#xD;
          -  post cardiopulmonary cerebral resuscitation within 4 weeks&#xD;
&#xD;
          -  taking immunosuppressants&#xD;
&#xD;
          -  receiving anti-cancer therapy&#xD;
&#xD;
          -  signed do not resuscitation&#xD;
&#xD;
          -  joined other clinical research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu-Tung Wu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chang Gung Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu-Tung Wu, MD</last_name>
    <phone>+886-3-3281200</phone>
    <phone_ext>3651</phone_ext>
    <email>overwinterwu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Tung Wu, MD</last_name>
      <phone>+886-3-3281200</phone>
      <phone_ext>3651</phone_ext>
      <email>overwinterwu@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, Hiesmayr M, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Oczkowski S, Szczeklik W, Bischoff SC. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019 Feb;38(1):48-79. doi: 10.1016/j.clnu.2018.08.037. Epub 2018 Sep 29.</citation>
    <PMID>30348463</PMID>
  </reference>
  <reference>
    <citation>Allingstrup M, Afshari A. Selenium supplementation for critically ill adults. Cochrane Database Syst Rev. 2015 Jul 27;(7):CD003703. doi: 10.1002/14651858.CD003703.pub3. Review.</citation>
    <PMID>26214143</PMID>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 29, 2020</study_first_submitted>
  <study_first_submitted_qc>December 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2020</study_first_posted>
  <last_update_submitted>August 12, 2021</last_update_submitted>
  <last_update_submitted_qc>August 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Abdomen, Acute</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Selenium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

